Joel W. Hay is professor and founder of the Department of Pharmaceutical Economics and Policy at the University of Southern California. He is a Health Economist at the Harbor UCLA Center for Vaccine Research. Dr. Hay has substantial experience in evaluation of treatments for upper respiratory infections having been a researcher on the USC Behavioral Economics for Adult Respiratory Infections (BEARI) NIH-funded multi-center trial. He has conducted numerous other federally-funded research projects, including the Antimicrobial Stewardship in Neonatal intensive Care Units Feedback Intervention demonstration project also sponsored by NIH.
He has substantial experience in conducting and analyzing surveys on depression, anxiety and economic burden of disease.
Dr. Hay is author of over 200 peer-reviewed scientific journal articles in health economics, pharmaceutical economics, health services research, health outcomes, statistics, econometrics, epidemiology and health care markets. He has over 600 peer-reviewed scientific conference presentations, abstracts, articles and letters to editors and over 10,000 scientific citations.
In addition to being a founder and founding Executive Board member of both the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Dr. Hay was founding Editor-in-Chief of Value in Health, the peer-reviewed scientific journal of ISPOR from 1998-2003. Value in Health became Medline-listed in 2002.